3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI
Esperion Therapeutics Completes Merger with Essence Parent Inc.
Stockholder Approval of Merger Agreement with Essence Parent Inc.
Amended material disclosure
Other Events
To be Acquired by
Annual Report to Security Holders
Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Q1
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
S-8 POS